MX356678B - Composición farmacéutica y combinación y métodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condición respiratoria. - Google Patents

Composición farmacéutica y combinación y métodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condición respiratoria.

Info

Publication number
MX356678B
MX356678B MX2013000806A MX2013000806A MX356678B MX 356678 B MX356678 B MX 356678B MX 2013000806 A MX2013000806 A MX 2013000806A MX 2013000806 A MX2013000806 A MX 2013000806A MX 356678 B MX356678 B MX 356678B
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
condition
methods
conditions associated
treating diseases
Prior art date
Application number
MX2013000806A
Other languages
English (en)
Spanish (es)
Other versions
MX2013000806A (es
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44899162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX356678(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130352/15A external-priority patent/RU2528093C2/ru
Priority claimed from RU2011125992/15A external-priority patent/RU2529783C2/ru
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of MX2013000806A publication Critical patent/MX2013000806A/es
Publication of MX356678B publication Critical patent/MX356678B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2013000806A 2010-07-21 2011-07-15 Composición farmacéutica y combinación y métodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condición respiratoria. MX356678B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010130352/15A RU2528093C2 (ru) 2010-07-21 2010-07-21 Фармацевтическая композиция и способ лечения острых и хронических заболевания дыхательной системы и синдрома кашля
RU2011125992/15A RU2529783C2 (ru) 2011-06-24 2011-06-24 Лекарственное средство для лечения патологического синдрома и способ лечения острых и хронических заболеваний дыхательноый системы и синдрома кашля
PCT/IB2011/002346 WO2012010973A2 (en) 2010-07-21 2011-07-15 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition

Publications (2)

Publication Number Publication Date
MX2013000806A MX2013000806A (es) 2013-10-28
MX356678B true MX356678B (es) 2018-06-08

Family

ID=44899162

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000806A MX356678B (es) 2010-07-21 2011-07-15 Composición farmacéutica y combinación y métodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condición respiratoria.

Country Status (22)

Country Link
US (2) US8795657B2 (enExample)
EP (1) EP2595655A2 (enExample)
JP (2) JP2013533269A (enExample)
CN (1) CN103200964A (enExample)
AR (1) AR082313A1 (enExample)
AU (1) AU2011281247B2 (enExample)
BR (1) BR112013001297A2 (enExample)
CA (1) CA2805978C (enExample)
CL (1) CL2013000202A1 (enExample)
DE (1) DE112011102412T5 (enExample)
EA (1) EA029228B1 (enExample)
ES (1) ES2425315R1 (enExample)
FR (1) FR2962909A1 (enExample)
GB (1) GB2496800B (enExample)
IT (1) ITTO20110638A1 (enExample)
MX (1) MX356678B (enExample)
MY (1) MY158522A (enExample)
NZ (1) NZ606977A (enExample)
PE (1) PE20130387A1 (enExample)
PH (1) PH12013500142A1 (enExample)
SG (1) SG187579A1 (enExample)
WO (1) WO2012010973A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
GB2495884B (en) 2010-07-15 2017-05-31 Iliich Epshtein Oleg A method of increasing the effect of an activated-potentiated form of an antibody
EA029436B1 (ru) 2010-07-15 2018-03-30 Олег Ильич ЭПШТЕЙН Комбинированная фармацевтическая композиция для лечения рассеянного склероза и инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способы лечения указанных заболеваний
CN103119061A (zh) 2010-07-21 2013-05-22 奥列格·伊里奇·爱泼斯坦 治疗注意力不足过动症的方法
US8795657B2 (en) * 2010-07-21 2014-08-05 Oleg I. Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
MX2013000804A (es) * 2010-07-21 2013-10-28 Oleg Iliich Epshtein Una composicion de combinacion farmaceutica y metodos para tratar la diabetes y los trastornos metabolicos.
WO2012010974A2 (en) * 2010-07-21 2012-01-26 Oleg Lliich Epshtein Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
CN103154030A (zh) * 2010-08-06 2013-06-12 奥列格·伊里奇·爱泼斯坦 复合药物组合物以及对传染性疾病进行治疗和预防的方法
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
DE102020007979A1 (de) 2020-12-29 2022-06-30 Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie Zusammensetzung zur Behandlung von lnfektionen mit Coronaviren

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
EP0663836B1 (en) 1992-10-08 1997-07-09 The Kennedy Institute Of Rheumatology Treatment of autoimmune and inflammatory disorders
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5629286A (en) 1994-03-31 1997-05-13 Brewitt; Barbara Homeopathic dilutions of growth factors
IL110035A0 (en) 1994-06-16 1994-10-07 Tapuach Natural Technologies 1 Homeopathic formulations
JPH11509452A (ja) 1996-02-12 1999-08-24 イリイッチ エプシュテイン，アリグ 薬物及び薬物によって生体を処置する方法
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
RU2114646C1 (ru) 1996-09-30 1998-07-10 Олег Ильич Эпштейн Способ повышения защитных свойств организма при воздействии внешних физических факторов
RU2103999C1 (ru) 1997-01-31 1998-02-10 Олег Ильич Эпштейн Способ лечения алкоголизма
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2199244C2 (ru) * 2000-10-05 2003-02-27 Самофалова Лариса Александровна Способ получения пищевой муки масличных семян
RU2191602C1 (ru) 2001-06-01 2002-10-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций
RU2197266C1 (ru) * 2001-06-01 2003-01-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения эрозивных и воспалительных заболеваний желудочно-кишечного тракта
RU2199344C1 (ru) * 2001-12-07 2003-02-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения синдрома кашля
RU2206338C1 (ru) 2001-12-07 2003-06-20 Эпштейн Олег Ильич Способ лечения синдрома кашля
RU2201255C1 (ru) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
RU2199345C1 (ru) 2001-12-26 2003-02-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции углеводного и жирового обмена
RU2209083C1 (ru) 2001-12-26 2003-07-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения кашля
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
CN101107003B (zh) 2003-03-14 2012-08-08 营养学研究有限公司 用于治疗疼痛和/或炎症的顺势疗法的配剂
RU2253478C1 (ru) 2003-10-01 2005-06-10 Эпштейн Олег Ильич Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества
US9308259B2 (en) * 2006-06-06 2016-04-12 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
JP2011518876A (ja) * 2008-04-29 2011-06-30 ガンヴァント、 デビチャンド オスワル、 ホメオパシー製剤
FR2962651A1 (fr) 2010-07-15 2012-01-20 Oleg Iliich Epshtein Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections fonctionnelles du tractus gastro-intestinal
ITTO20110631A1 (it) 2010-07-15 2012-01-16 Oleg Iliich Epshtein Composizione farmaceutica di combinazione e metodi per trattare patologie del sistema genitourinario
EA029436B1 (ru) * 2010-07-15 2018-03-30 Олег Ильич ЭПШТЕЙН Комбинированная фармацевтическая композиция для лечения рассеянного склероза и инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способы лечения указанных заболеваний
NZ606768A (en) * 2010-07-15 2015-08-28 Oleg Iliich Epshtein Pharmaceutical compositions and methods of treatment
WO2012010974A2 (en) 2010-07-21 2012-01-26 Oleg Lliich Epshtein Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
US8795657B2 (en) * 2010-07-21 2014-08-05 Oleg I. Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
MX2013000804A (es) 2010-07-21 2013-10-28 Oleg Iliich Epshtein Una composicion de combinacion farmaceutica y metodos para tratar la diabetes y los trastornos metabolicos.
CN103154030A (zh) 2010-08-06 2013-06-12 奥列格·伊里奇·爱泼斯坦 复合药物组合物以及对传染性疾病进行治疗和预防的方法

Also Published As

Publication number Publication date
CL2013000202A1 (es) 2015-01-16
ITTO20110638A1 (it) 2012-01-22
US20120225074A1 (en) 2012-09-06
CA2805978A1 (en) 2012-01-26
CN103200964A (zh) 2013-07-10
ES2425315A2 (es) 2013-10-14
NZ606977A (en) 2015-08-28
EA201300131A1 (ru) 2013-11-29
US8795657B2 (en) 2014-08-05
EA029228B1 (ru) 2018-02-28
MX2013000806A (es) 2013-10-28
GB2496800B (en) 2018-05-23
PH12013500142A1 (en) 2013-03-11
FR2962909A1 (fr) 2012-01-27
GB2496800A (en) 2013-05-22
GB201302926D0 (en) 2013-04-03
AR082313A1 (es) 2012-11-28
ES2425315R1 (es) 2014-09-08
WO2012010973A3 (en) 2012-04-26
PE20130387A1 (es) 2013-03-30
SG187579A1 (en) 2013-03-28
MY158522A (en) 2016-10-14
AU2011281247A1 (en) 2013-03-14
CA2805978C (en) 2016-06-28
BR112013001297A2 (pt) 2017-11-21
EP2595655A2 (en) 2013-05-29
WO2012010973A2 (en) 2012-01-26
AU2011281247B2 (en) 2015-07-30
JP2013533269A (ja) 2013-08-22
DE112011102412T5 (de) 2013-07-04
US20150023985A1 (en) 2015-01-22
JP2016216479A (ja) 2016-12-22

Similar Documents

Publication Publication Date Title
GB2496800A (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
BR112012001297A2 (pt) conector.
AU2018253544A1 (en) Methods for treating or preventing asthma by administering an IL-4R antagonist
PH12013500108A1 (en) Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
EA201591269A1 (ru) Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта
PH12018500960A1 (en) Processes for preparing isoquinolinones and solid forms of isoquinolinones
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
UA118453C2 (uk) Спосіб лікування пухлин у пацієнта
PH12014500468A1 (en) Heterocyclic compounds and uses thereof
HK1215681A1 (zh) 使用白细胞介素-10治疗疾病和病症的方法
MX2014002395A (es) Inhibidores de rock suaves, novedosos.
HK1208231A1 (en) Treatment for rheumatoid arthritis
EA201290603A1 (ru) Способ лечения
HK1217092A1 (zh) 治疗性化合物及其用途
MX2012013879A (es) Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas.
SG10201807318RA (en) Methods for treating chronic obstructive pulmonary disease using benralizumab
MY184647A (en) Arylated camphenes, processes for their preparation and uses thereof
GB2496795A (en) A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
WO2011060253A3 (en) Methods of treating diseases, pharmaceutical compositions, and pharmaceutical dosage forms
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
WO2013153349A3 (en) Pharmaceutical composition comprising arformoterol and fluticasone furoate
WO2014155268A3 (en) Fgf-r tyrosine kinase activity inhibitors - use in diseases associated with lack of or reduced snf5 activity
UA89921C2 (ru) Способ лечения хронического обструктивного заболевания лёгких при помощи месалазина
MX2012014799A (es) Composición medicinal, método de preparación y uso de la misma.
MX2019009243A (es) Antagonistas il-4r para usarse en el tratamiento o previncion de asma persistente y asma severa.

Legal Events

Date Code Title Description
FG Grant or registration